Laparoscopic hepatectomy surgery
Conditions
Brief summary
The main objective of the trial is the reduction of intraoperative bleeding, which will be measured through milliliters of blood lost at the end of surgery, decrease in hemoglobin, hematocrit, platelets and fibrinogen values.
Detailed description
Changes in heart rate and blood pressure during surgery., Need for transfusion of blood products during surgery and later during the immediate perioperative 24-72h., Need for the use of vasoactive drugs during surgery and if needed, we will indicate when they can be withdrawn., Number of clampings and their duration with monitoring of hemodynamic stability during surgery., Hepatic function and its recovery after surgery, control of hemogram and coagulation after 24h, at discharge and at 3 months., Evaluation of admissions after surgery up to three months later related to any post-surgical complication.
Interventions
DRUGOCTREOTIDE
Sponsors
University Clinic Of Navarra
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main objective of the trial is the reduction of intraoperative bleeding, which will be measured through milliliters of blood lost at the end of surgery, decrease in hemoglobin, hematocrit, platelets and fibrinogen values. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in heart rate and blood pressure during surgery., Need for transfusion of blood products during surgery and later during the immediate perioperative 24-72h., Need for the use of vasoactive drugs during surgery and if needed, we will indicate when they can be withdrawn., Number of clampings and their duration with monitoring of hemodynamic stability during surgery., Hepatic function and its recovery after surgery, control of hemogram and coagulation after 24h, at discharge and at 3 months., Evaluation of admissions after surgery up to three months later related to any post-surgical complication. | — |
Countries
Spain
Outcome results
None listed